We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RENX:NASDAQRenX Enterprises Corp. Analysis

Data as of 2026-05-19 - not real-time

$1.51

Latest Price

9/10Risk

Risk Level: High

Executive Summary

RenX Enterprises Corp. (RENX) is trading at a deep discount of $1.505, well below its 20‑day SMA of 2.30 and 50‑day SMA of 2.41, with the 200‑day SMA still hovering near 12.12. Technical momentum is bearish, confirmed by an RSI of 32 (near oversold) and a MACD histogram that remains negative, while volume has been on a decreasing trend. The stock exhibits extreme short‑term volatility at 138 % over the past 30 days and a beta of 2.29, indicating amplified price swings relative to the market. Fundamentally, the company is distressed: it carries a debt‑to‑equity ratio of over 2,100 %, negative operating and profit margins (‑70 % and ‑190 % respectively), and a massive max drawdown of ‑96 %. Recent material news includes a PIPE financing commitment of $13 million (with up to $87 million optional) and a logistics segment that has turned profitable, yet cash burn remains severe with negative operating cash flow.
The reverse stock split announced to regain Nasdaq compliance underscores the liquidity challenges, and with a market cap of only $3.8 million the stock is highly illiquid. While the price‑to‑book (0.32) and price‑to‑sales (0.31) ratios suggest a superficial undervaluation, the combination of high leverage, ongoing losses, and a bearish technical backdrop makes the investment highly speculative.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Price below short‑term moving averages and bearish MACD signal
  • Extreme volatility and high beta magnify downside risk
  • Decreasing volume and low market cap create liquidity constraints

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Recent PIPE financing may improve cash position
  • Logistics segment achieving profitability offers a modest earnings tailwind
  • Debt load remains excessive and earnings are still negative

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Sustained negative margins and massive debt hinder a credible turnaround
  • Real estate development exposure to cyclical and regulatory pressures
  • Absence of dividend and analyst coverage limits investor confidence

Key Metrics & Analysis

Financial Health

Revenue Growth21683.80%
Profit Margin-190.01%
ROE-3006.93%
ROA-33.25%
Debt/Equity2139.62
P/B Ratio0.3
Op. Cash Flow$-8495325
Free Cash Flow$-3072874
Industry P/E32.2

Technical Analysis

TrendBearish
RSI32.1
Support$1.47
Resistance$2.90
MA 20$2.30
MA 50$2.41
MA 200$12.12
MACDBearish
VolumeDecreasing
Fear & Greed Index89.59

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta2.29
Volatility137.98%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.